130 related articles for article (PubMed ID: 26621801)
1. Mucosal delivery of allergen peptides expressed by Lactococcus lactis inhibit allergic responses in a BALB/c mouse model.
Ai C; Zhang Q; Ding J; Wang G; Liu X; Tian F; Zhao J; Zhang H; Chen W
Appl Microbiol Biotechnol; 2016 Feb; 100(4):1915-1924. PubMed ID: 26621801
[TBL] [Abstract][Full Text] [Related]
2. Genetically engineered Lactococcus lactis protect against house dust mite allergy in a BALB/c mouse model.
Ai C; Zhang Q; Ren C; Wang G; Liu X; Tian F; Zhao J; Zhang H; Chen YQ; Chen W
PLoS One; 2014; 9(10):e109461. PubMed ID: 25290938
[TBL] [Abstract][Full Text] [Related]
3. Suppression of dust mite allergy by mucosal delivery of a hypoallergenic derivative in a mouse model.
Ai C; Zhang Q; Ding J; Ren C; Wang G; Liu X; Tian F; Zhao J; Zhang H; Chen YQ; Chen W
Appl Microbiol Biotechnol; 2015 May; 99(10):4309-19. PubMed ID: 25661808
[TBL] [Abstract][Full Text] [Related]
4. T cell epitope immunotherapy ameliorates allergic responses in a murine model of shrimp allergy.
Wai CY; Leung NY; Leung PS; Chu KH
Clin Exp Allergy; 2016 Mar; 46(3):491-503. PubMed ID: 26610061
[TBL] [Abstract][Full Text] [Related]
5. Oral Immunotherapy Using Probiotic Ice Cream Containing Recombinant Food-Grade
Vasiee A; Falah F; Sankian M; Tabatabaei-Yazdi F; Mortazavi SA
J Immunol Res; 2020; 2020():2635230. PubMed ID: 33029537
[TBL] [Abstract][Full Text] [Related]
6. Allergen-specific immunosuppression by mucosal treatment with recombinant Ves v 5, a major allergen of Vespula vulgaris venom, in a murine model of wasp venom allergy.
Winkler B; Bolwig C; Seppälä U; Spangfort MD; Ebner C; Wiedermann U
Immunology; 2003 Nov; 110(3):376-85. PubMed ID: 14632666
[TBL] [Abstract][Full Text] [Related]
7. Sublingual Immunotherapy with Sal k1 Expressing Lactococcus lactis Down-regulates Th2 Immune Responses in Balb/c Mice.
Ghasemi Z; Varasteh AR; Moghadam M; Jalali SA; Anissian A; Sankian M
Iran J Allergy Asthma Immunol; 2018 Jun; 17(3):281-290. PubMed ID: 29908546
[TBL] [Abstract][Full Text] [Related]
8. Non-anaphylactic combination of partially deleted fragments of the major house dust mite allergen Der f 2 for allergen-specific immunotherapy.
Takai T; Mori A; Yuuki T; Okudaira H; Okumura Y
Mol Immunol; 1999; 36(15-16):1055-65. PubMed ID: 10698308
[TBL] [Abstract][Full Text] [Related]
9. Induction of ovalbumin-specific tolerance by oral administration of Lactococcus lactis secreting ovalbumin.
Huibregtse IL; Snoeck V; de Creus A; Braat H; De Jong EC; Van Deventer SJ; Rottiers P
Gastroenterology; 2007 Aug; 133(2):517-28. PubMed ID: 17681173
[TBL] [Abstract][Full Text] [Related]
10. Developments in allergen-specific immunotherapy: from allergen extracts to allergy vaccines bypassing allergen-specific immunoglobulin E and T cell reactivity.
Focke M; Swoboda I; Marth K; Valenta R
Clin Exp Allergy; 2010 Mar; 40(3):385-97. PubMed ID: 20210812
[TBL] [Abstract][Full Text] [Related]
11.
Li J; Yang L; Wang J; Yang Y; Wu Y; Jiang Q; Yang Y; Ma D; Zhang R; Huang N; Li W; Liu G; Zhu R
J Immunol; 2019 Jul; 203(1):31-38. PubMed ID: 31092638
[No Abstract] [Full Text] [Related]
12. Modulation of allergic immune responses by mucosal application of recombinant lactic acid bacteria producing the major birch pollen allergen Bet v 1.
Daniel C; Repa A; Wild C; Pollak A; Pot B; Breiteneder H; Wiedermann U; Mercenier A
Allergy; 2006 Jul; 61(7):812-9. PubMed ID: 16792578
[TBL] [Abstract][Full Text] [Related]
13. Oral administration of allergen extracts from mugwort pollen desensitizes specific allergen-induced allergy in mice.
Ma WJ; Bao MJ; Zhu JP; Yao HY; Xie YC; Guan Y; Li FF; Dong XW; Zheng YM; Xie QM
Vaccine; 2012 Feb; 30(8):1437-44. PubMed ID: 22240342
[TBL] [Abstract][Full Text] [Related]
14. Engineering of major house dust mite allergens Der p 1 and Der p 2 for allergen-specific immunotherapy.
Asturias JA; Ibarrola I; Arilla MC; Vidal C; Ferrer A; Gamboa PM; Viñuela JE; Sanz ML; Andreu C; Martínez A
Clin Exp Allergy; 2009 Jul; 39(7):1088-98. PubMed ID: 19400901
[TBL] [Abstract][Full Text] [Related]
15. Laser-facilitated epicutaneous immunotherapy to IgE-mediated allergy.
Kumar MNK; Zhou C; Wu MX
J Control Release; 2016 Aug; 235():82-90. PubMed ID: 27235977
[TBL] [Abstract][Full Text] [Related]
16. Mucosal co-application of lactic acid bacteria and allergen induces counter-regulatory immune responses in a murine model of birch pollen allergy.
Repa A; Grangette C; Daniel C; Hochreiter R; Hoffmann-Sommergruber K; Thalhamer J; Kraft D; Breiteneder H; Mercenier A; Wiedermann U
Vaccine; 2003 Dec; 22(1):87-95. PubMed ID: 14604575
[TBL] [Abstract][Full Text] [Related]
17. Immunotherapy with a recombinant hybrid molecule alleviates allergic responses more efficiently than an allergenic cocktail or pollen extract in a model of chenopodium album allergy.
Nouri HR; Sankian M; Afsharzadeh D; Varasteh A
Int Arch Allergy Immunol; 2013; 161(4):325-32. PubMed ID: 23689669
[TBL] [Abstract][Full Text] [Related]
18. Vaccination with DNA encoding human T-cell epitopes suppresses Der p induced allergic responses in mice.
Kwon SS; Kim NS; Yoo TJ
J Asthma; 2005 Mar; 42(2):119-25. PubMed ID: 15871444
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness and safety of oral lactococci-based vaccine encoding triple common allergens to prevent airway allergy in mice.
Lee MF; Chiang CH; Lin SJ; Wu CS; Chen YH
PLoS One; 2021; 16(12):e0261333. PubMed ID: 34972127
[TBL] [Abstract][Full Text] [Related]
20. Design and evaluation of a hypoallergenic peptide-based vaccine for Salsola kali allergy.
Tabesh S; Fanuel S; Fazlollahi MR; Yekaninejad MS; Kardar GA; Razavi SA
Int Immunopharmacol; 2019 Jan; 66():62-68. PubMed ID: 30445308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
